Herculase???? II Fusion DNA polymerase, 40 rxn and 3 more items

Agilent Technologies Inc. was awarded a contract by the University of Virginia on July 16, 2026, with a cumulative value of $304. The contract, identified as A207_PO-0455875-V2, involves the procurement of molecular biology reagents and associated tariff charges. The primary deliverables include Herculase II Fusion DNA polymerase (1 unit at $60.07), Pfu Ultra II Fusion HS DNA polymerase (2 units at $118.40 each), and two tariff charges totaling $7.42. Deliveries are directed to Jessica L Snow and the Buyer at the University of Virginia in Virginia.

The contract encompasses the supply of polymerase enzymes commonly utilized in molecular biology and genetic research applications. The specific line items suggest this procurement supports laboratory research activities requiring high-fidelity DNA synthesis and amplification capabilities. No contract performance period dates are specified in the available documentation; however, the award date of July 16, 2026, establishes the official contract inception. The relatively modest cumulative contract value of $304 indicates this represents a small-value purchase order for research consumables rather than a large-scale procurement.